MEDIFAST INC
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
MED$13.37+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Page | ||
|---|---|---|
| PART I | ||
| Item 1 | Business | 4 |
| Item 1A | Risk Factors | 17 |
| Item 1B | Unresolved Staff Comments | 28 |
| Item 1C | Cybersecurity | 28 |
| Item 2 | Properties | 29 |
| Item 3 | Legal Proceedings | 30 |
| Item 4 | Mine Safety Disclosures | 30 |
| PART II | ||
| Item 5 | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 31 |
| Item 7 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 32 |
| Item 7A | Quantitative and Qualitative Disclosures about Market Risk | 39 |
| Item 8 | Financial Statements and Supplementary Data | 40 |
| Item 9 | Changes in and Disagreements with Accountants on Accounting and Financial Disclosures | 62 |
| Item 9A | Controls and Procedures | 62 |
| Item 9B | Other Information | 63 |
| Item 9C | Disclosure Regarding Foreign Jurisdictions That Prevent Inspections | 63 |
| PART III | ||
| Item 10 | Directors, Executive Officers and Corporate Governance | 64 |
| Item 11 | Executive Compensation | 64 |
| Item 12 | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 64 |
| Item 13 | Certain Relationships and Related Transactions, and Director Independence | 64 |
| Item 14 | Principal Accountant Fees and Services | 64 |
| PART IV | ||
| Item 15 | Exhibits and Financial Statement Schedules | 65 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.